Scholar Rock Holding Corp (NAS:SRRK)
$ 9.43 -0.4 (-4.07%) Market Cap: 752.08 Mil Enterprise Value: 605.68 Mil PE Ratio: 0 PB Ratio: 4.12 GF Score: 55/100

Scholar Rock Holding Corp SRK-015 Interim Phase 1 Results and Phase 2 Trial Design Conference Call Transcript

Feb 26, 2019 / 01:00PM GMT
Release Date Price: $18.3 (-1.13%)
Operator

Good day, ladies and gentlemen, and welcome to the Scholar Rock SRK-015 Interim Phase 1 results and Phase 2 overview. (Operator Instructions)

I would now like to hand the call over to Ms. Catherine Hu, Investor Relations. You may begin.

Catherine Hu
Scholar Rock Holding Corp. - Executive Director of Investor Relations & Corporate Communications

Thanks, Amanda. Good morning, and thank you for joining us on today's call to discuss the interim results from the Phase 1 trial of SRK-015 in healthy volunteers and an overview of the Phase 2 trial in SMA.

Today's call will be led by Nagesh Mahanthappa, our President, CEO; and Yung Chyung, our Chief Medical Officer. Nagesh and Yung will be joined by Alan Buckler, our Chief Scientific Officer; and Rhonda Chicko, our Chief Financial Officer for Q&A.

The webcast slides can be downloaded on the Events & Presentations section of the Investor Relations page on the Scholar Rock website.

Before I turn it over to Nagesh, I wanted you to know that we'll be making various

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot